Nothing Special   »   [go: up one dir, main page]

NL8004837A - Cinnamoylpiperidinobutyrofenonen met anti-psychotische werking. - Google Patents

Cinnamoylpiperidinobutyrofenonen met anti-psychotische werking. Download PDF

Info

Publication number
NL8004837A
NL8004837A NL8004837A NL8004837A NL8004837A NL 8004837 A NL8004837 A NL 8004837A NL 8004837 A NL8004837 A NL 8004837A NL 8004837 A NL8004837 A NL 8004837A NL 8004837 A NL8004837 A NL 8004837A
Authority
NL
Netherlands
Prior art keywords
pharmaceutically acceptable
acid addition
compound according
acceptable acid
cinnamoyl
Prior art date
Application number
NL8004837A
Other languages
English (en)
Dutch (nl)
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of NL8004837A publication Critical patent/NL8004837A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL8004837A 1979-09-04 1980-08-27 Cinnamoylpiperidinobutyrofenonen met anti-psychotische werking. NL8004837A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7249879 1979-09-04
US06/072,498 US4284636A (en) 1979-09-04 1979-09-04 Cinnamoylpiperidinobutyrophenone antipsychotic agents

Publications (1)

Publication Number Publication Date
NL8004837A true NL8004837A (nl) 1981-03-06

Family

ID=22107979

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8004837A NL8004837A (nl) 1979-09-04 1980-08-27 Cinnamoylpiperidinobutyrofenonen met anti-psychotische werking.

Country Status (14)

Country Link
US (1) US4284636A (it)
JP (1) JPS5640665A (it)
AU (1) AU533712B2 (it)
BE (1) BE885017A (it)
CA (1) CA1147734A (it)
CH (1) CH646691A5 (it)
DE (1) DE3031892A1 (it)
ES (1) ES494222A0 (it)
FR (1) FR2464251A1 (it)
GB (1) GB2057445B (it)
IL (1) IL60739A (it)
IT (1) IT1145444B (it)
NL (1) NL8004837A (it)
ZA (1) ZA804661B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3245190B1 (en) 2015-01-16 2018-12-26 Bayer CropScience Aktiengesellschaft Method for preparing 4-cyanopiperidine hydrochloride
EP3553179A1 (en) 2018-04-12 2019-10-16 Universität Bielefeld Enantioselective biocatalytic preparation of 4-cyano-substituted 1-aminoindane and ozanimod

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
US3816433A (en) * 1965-03-24 1974-06-11 Ferrosan Ab 4-fluoro-ypsilon-(4-methylpiperidino)-butyrophenone and its pharmaceutically acceptable salts
US3689492A (en) * 1965-09-10 1972-09-05 Hans Detlef Schroeder 1-{8 4{40 -OXO-4-(p-FLUOROPHENYL)-n-BUTYL-1{40 {9 -4-ACETYL-4-(m-HYDROXY-PHENYL-PIPERIDINE
US3646014A (en) * 1966-05-09 1972-02-29 Aldrich Chem Co Inc Chemical compounds
US3484446A (en) * 1967-01-16 1969-12-16 Aldrich Chem Co Inc 1-(3-(4-fluorobenzoyl)propyl) - and 1 - (1,1-ethylenedioxy - 1 - (4 - fluorophenyl)-4-butyl)-4-piperidyl carbamates
NL130760C (it) * 1967-01-25
CH516557A (de) 1967-12-01 1971-12-15 Thomae Gmbh Dr K Verfahren zur Herstellung neuer Zimtsäureamide
CH532049A (de) * 1967-12-01 1973-02-15 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Zimtsäureamiden
US3576810A (en) * 1968-06-20 1971-04-27 Robins Co Inc A H 1-substituted-3-(-4)-aroylpiperidines
US3637712A (en) * 1970-01-26 1972-01-25 Bristol Myers Co Piperidylpropanol compounds
US3799932A (en) * 1970-03-20 1974-03-26 Sumitomo Chemical Co Gamma-piperidinobutyrophenones
ZA717147B (en) * 1970-11-27 1972-07-26 Richardson Merrell Inc 4-(4-(alpha-hydroxybenzyl)piperidino)-4'-fluorobutyrophenone derivatives
US4101662A (en) * 1973-05-03 1978-07-18 A. H. Robins Company, Incorporated Method for inhibiting emesis and compositions therefor
SE7409245L (it) * 1973-07-19 1975-01-20 Robins Co Inc A H
GB1535791A (en) * 1975-05-07 1978-12-13 Ferrosan Ab Derivatives of 4-piperidinol
CH602642A5 (it) * 1975-11-14 1978-07-31 Orgamol Sa

Also Published As

Publication number Publication date
ES8106143A1 (es) 1981-08-01
CA1147734A (en) 1983-06-07
GB2057445A (en) 1981-04-01
GB2057445B (en) 1983-11-30
IL60739A (en) 1984-02-29
FR2464251A1 (fr) 1981-03-06
DE3031892A1 (de) 1981-03-19
BE885017A (fr) 1980-12-31
IT8049544A0 (it) 1980-08-22
ZA804661B (en) 1981-07-29
AU533712B2 (en) 1983-12-08
CH646691A5 (de) 1984-12-14
FR2464251B1 (it) 1983-05-20
IL60739A0 (en) 1980-10-26
JPS6344147B2 (it) 1988-09-02
JPS5640665A (en) 1981-04-16
ES494222A0 (es) 1981-08-01
AU6149180A (en) 1981-03-12
IT1145444B (it) 1986-11-05
US4284636A (en) 1981-08-18

Similar Documents

Publication Publication Date Title
Chen et al. Synthesis and anti-inflammatory activity of resveratrol analogs
Geissman et al. The synthesis of some intermediates for use in the preparation of analogs of salicylaldehyde ethylenediimine cobalt (“salcomine”)
DE2524929A1 (de) Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
JPS5938230B2 (ja) 新規なイソキサゾ−ル誘導体およびその製法
DE3129309A1 (de) Hypoglykaemische 5-substituierte oxazolidin-2,4-dione
GB2054566A (en) 1-aryl-4-arylsulphonyl-3-aminopropoxy-1h-pyrazoles medicaments containing them and processes for their preparation
FR2595695A1 (fr) Derives de n-(((hydroxy-2 phenyl) (phenyl) methylene) amino-2) ethyl) acetamide, leur preparation et leur application en therapeutique
DE3442860A1 (de) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3- on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2811031A1 (de) Piperazin-3-indole, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE1695774A1 (de) Neue Benzophenon-Derivate
CZ284238B6 (cs) Substituované beta-diketony, způsob jejich výroby a farmaceutický přípravek, který je obsahuje
NL8004837A (nl) Cinnamoylpiperidinobutyrofenonen met anti-psychotische werking.
DE2524959A1 (de) Neue isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
DE3132915A1 (de) 1,5-diphenylpyrazolin-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0072961B1 (de) 1-Phenylindazol-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2637596A1 (fr) Methyl-4 ((aryl-4 piperazinyl-1)-2 ethyl)-5 thiazole et ses derives, leur procede de preparation et les medicaments en contenant
GB2053897A (en) Piperazine derivatives
US4283404A (en) Aroylethenylpiperidinobutyrophenone antipsychotic agents
Stillings et al. Substituted 5H-dibenz [b, g]-1, 4-oxazocines and related amino acids with antiinflammatory activity
DD295373A5 (de) Verfahren zur herstellung von alpha-cyan-beta-oxopropionamiden
JPS6044307B2 (ja) 新規のo−アルキル化オキシムおよび医薬としてのその用途
US4189607A (en) Anilionotropone derivatives
CA1148162A (en) 4-(4-alkyl-4-aroyl-1-piperidino)- butyrophenone antipsychotic agents
JPS6323874A (ja) 2,6−ピペラジンジオンの新しい誘導体、その製造方法及びその含有医薬組成物
CS196302B2 (cs) Způsob výroby nových substituovaných arylalkylaminů

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed